Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease
Abraham Michael Lincoff, Stephen James Nicholls, Jeffrey Riesmeyer, Philip J. Barter, H Bryan Brewer, Keith A.A. Fox, Charles Michael Gibson, Christopher Bull Granger, Venu Menon, Gilles Montalescot, Daniel James Rader, Alan R. Tall, Ellen Strauss McErlean, Kathy Wolski, Giacomo Ruotolo, Burkhard Vangerow, Govinda J. Weerakkody, Shaun G. Goodman, Diego Conde, Darren K. McGuire, José Carlos Nicolau, Jose Luis Leiva-Pons, Yves Pesant, Weimin Li, David Kandath, and 4 more
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.
Record
- Archive ID
- doi:10.1056/nejmoa1609581
- Published
- May 17, 2017
- Venue
- New England Journal of Medicine
- DOI
- 10.1056/nejmoa1609581
- PubMed
- 28514624
- Categories
- Lipoproteins and Cardiovascular Health
- Provenance
- openalex